Small-Molecule APIs

Apr 20, 2018
By Pharmaceutical Technology Editors
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
Mar 02, 2018
Pharmaceutical Technology
Assessing potential formulation and manufacturing issues in early development phases can improve a drug’s chances for success.
Feb 01, 2018
By Pharmaceutical Technology Editors
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
Feb 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests in development and laboratory facilities and adds staff.
Jan 16, 2018
By Pharmaceutical Technology Editors
A ceremony was held at Cambrex’s Karlskoga facility to mark the commencement of a long-term manufacturing agreement with AstraZeneca for a key intermediate.
Jan 02, 2018
Pharmaceutical Technology
FDA looks to achieve near-record level of new drug approvals following slowdown in 2016.
Dec 18, 2017
By Pharmaceutical Technology Editors
MJR PharmJet's MicroJet Reactor technology is a continuous process for producing nanoparticles with tightly controlled particle size and particle size distribution.
Nov 20, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Avista Pharma Solutions facility and equipment upgrades at its Longmont, Colorado facility support processing of potent compounds.
Oct 17, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site
Sep 26, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Additional reactor capacity and a wastewater processing plant increase API manufacturing capacity at the Cambrex site in Kalskoga, Sweden.
native1_300x100
lorem ipsum